An alternative synthesis of D-erythro-sphingosine and L-lyxo-phytosphingosine

DOI: 10.1016/S0040-4039(99)01906-1

Source and publish data:

Tetrahedron Letters p. 9063 - 9064 (1999)

Update date:2022-07-29

Topics:

Authors:

Nakamura, Tsuyoshi

Shiozaki, Masao

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/S0040-4039(99)01906-1

Chiral β-lactam 1 obtained from D-(-)-tartaric acid was converted to a D-erythro-sphingosine equivalent 7 in 35% yield, without yielding a 4Z-geometrical isomer, and L-lyxo-phytosphingosine 8 in 45% yield, respectively.

Full text of DOI:10.1016/S0040-4039(99)01906-1

Products guided by the article

Product name:Carbamic acid, [(1S,2S,3S)-2-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-3-hydroxy-1-[[[tris(1- methylethyl)silyl]oxy]methyl]heptadecyl]-, 1,1-dimethylethyl ester

Cas No:395069-18-8

R&D Labs maybe for 395069-18-8

AURORA CHEMICAL CO., LTD

Contact:86-532-68629711 13780605697

Address:NO 220 YANAN 3 ROAD,(POST ADMINISTRATION BUILDING),QINGDAO,CHINA
Shanghai Dianyang Industry Co.,ltd

Contact:+86 21 6492 4669

Address:Chejing RD, Songjiang District, Shanghai, China
Zibo Linzi Darong Fine Chemical Co., Ltd(expird)

Contact:86-532-67773200; 15689126900

Address:Qidu town,Linzi district,Zibo city,Shandong province,China
ANTAI BIO-TECH CO LTD

website:http://www.antaibio.com

Contact:0086-21-65663057

Address:Room 2108, Building 2，No. 489 Zhengli Road，200433
Zhushan County Tianxin Pharmaceutical & Chemical Co., Ltd.

Contact:0086-719-4224892

Address:Tutang Road, Chengguan Town, Zhushan County, Hubei Province

Relevant to this article

Development of a stereoselective practical synthetic route to indolmycin, a candidate anti-H. pylori agent

Doi:10.1248/cpb.49.1604
(2001)
Doi:10.1039/P19720002915
(1972)
The first vanadium-catalyzed oxidation of aryl allylic selenides with in situ [2,3] sigmatropic rearrangement

Doi:10.1039/b006278m
(2000)
Doi:10.1246/bcsj.45.3607
(1972)
Doi:10.1021/jm00281a029
(1972)
Microwave-assisted synthesis and antitumor evaluation of a new series of thiazolylcoumarin derivatives

Doi:10.17179/excli2017-208
(2017)

Article Doi